Correlation Between Aileron Therapeutics and Artelo Biosciences
Can any of the company-specific risk be diversified away by investing in both Aileron Therapeutics and Artelo Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aileron Therapeutics and Artelo Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aileron Therapeutics and Artelo Biosciences, you can compare the effects of market volatilities on Aileron Therapeutics and Artelo Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aileron Therapeutics with a short position of Artelo Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aileron Therapeutics and Artelo Biosciences.
Diversification Opportunities for Aileron Therapeutics and Artelo Biosciences
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Aileron and Artelo is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Aileron Therapeutics and Artelo Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artelo Biosciences and Aileron Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aileron Therapeutics are associated (or correlated) with Artelo Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artelo Biosciences has no effect on the direction of Aileron Therapeutics i.e., Aileron Therapeutics and Artelo Biosciences go up and down completely randomly.
Pair Corralation between Aileron Therapeutics and Artelo Biosciences
Given the investment horizon of 90 days Aileron Therapeutics is expected to under-perform the Artelo Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Aileron Therapeutics is 1.2 times less risky than Artelo Biosciences. The stock trades about -0.39 of its potential returns per unit of risk. The Artelo Biosciences is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 114.00 in Artelo Biosciences on August 29, 2024 and sell it today you would lose (4.00) from holding Artelo Biosciences or give up 3.51% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aileron Therapeutics vs. Artelo Biosciences
Performance |
| Timeline |
| Aileron Therapeutics |
| Artelo Biosciences |
Aileron Therapeutics and Artelo Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aileron Therapeutics and Artelo Biosciences
The main advantage of trading using opposite Aileron Therapeutics and Artelo Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aileron Therapeutics position performs unexpectedly, Artelo Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artelo Biosciences will offset losses from the drop in Artelo Biosciences' long position.| Aileron Therapeutics vs. Bright Minds Biosciences | Aileron Therapeutics vs. HP Inc | Aileron Therapeutics vs. Intel | Aileron Therapeutics vs. Chevron Corp |
| Artelo Biosciences vs. Aileron Therapeutics | Artelo Biosciences vs. Histogen | Artelo Biosciences vs. Curis Inc | Artelo Biosciences vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |